Gender differences in the control of cardiovascular risk factors in patients with type 2 diabetes -A cross-sectional study

Internal Medicine

Volumn 51, Issue 2, 2012, Pages 161-166

  Šekerija, Mario ^a   Poljičanin, Tamara ^a   Erjav, Katja ^b   Liberati Čizmek, Ana Marija ^a   Prašek, Manja ^a   Metelko, Željko ^a,b  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Gender; Risk factors

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CROATIA; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE CONTROL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 84856004436     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6094     Document Type: Article

References (32)

1. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. World Health Organization, Geneva, 1999.
2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 33: S62-S69, 2010.
3. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998.
4. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14, 2010.
5. International Diabetes Federation. IDF Diabetes Atlas. In: International Diabetes Federation. 4th ed. Brussels, Belgium, 2009.
6. Metelko Z, Pavlic-Renar I, Poljicanin T, Szirovitza L, Turek S. Prevalence of diabetes mellitus in Croatia. Diabetes Res Clin Pract 81: 263-267, 2008.
7. Mann D, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med 169: 1718-1720, 2009.
8. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies. BMJ 332: 73-78, 2006.
9. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 281: 1291-1297, 1999.
10. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147: 149-155, 2007.
11. Goldschmid M, Barrett-Connor E, Edelstein S, Wingard D, Cohn B, Herman W. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 89: 991-997, 1994.
12. Cowie C, Harris M. Physical and Metabolic Characteristics of Persons with Diabetes. In: Diabetes in America. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2nd ed. National Diabetes Data Group, Ed. NIH Publication No. 95-1468, 1995: 117-176.
13. Wexler D, Grant R, Meigs J, Nathan D, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28: 514-520, 2005.
14. Vaccaro O, Boemi M, Cavalot F, et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis 198: 396-402, 2008.
15. Fremont A, Correa-de-Araujo R, Hayes S. Gender disparities in managed care: it's time for action. Womens Health Issues 17: 116-119, 2007.
16. Ferrara A, Mangione C, Kim C, et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 31: 69-74, 2008.
17. Nau D, Mallya U. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization. Am J Manag Care 11: 69-73, 2005.
18. Stratton I, Adler A, Neil H, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412, 2000.
19. Croatian National Institute of Public Health. Croatian Health Service Yearbook 2008. Croatian National Institute of Public Health, Zagreb, Croatia, 2009.
20. Poljicanin T, Pavlic-Renar I, Metelko Z. CroDiab NET--electronic diabetes registry. Acta Med Croatica 59: 185-189, 2005 (in Croatian, Abstract in English).
21. Piwernetz K, Home P, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee. Diabet Med 10: 371-377, 1993.
22. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136, 2007.
23. Executive summary: Standards of medical care in diabetes--2010. Diabetes Care 33: S4-S10, 2010.
24. Khattab M, Khader Y, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 24: 84-89, 2010.
25. Fox K, Gerber Pharmd R, Bolinder B, Chen J, Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002. Clin Ther 28: 388-395, 2006.
26. Saaddine J, Cadwell B, Gregg E, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144: 465-474, 2006.
27. Berthold H, Gouni-Berthold J, Bestehorn K, Böhm M, Krone W. Cardiovascular risk factors in patients with type 2 diabetes in Germany. Dtsch Ärztebl 104: A861-A867, 2007.
28. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complica tions. J Hypertens 11: 309-317, 1993.
29. Howard B, Cowan L, Go O, Welty T, Robbins D, Lee E. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21: 1258-1265, 1998.
30. Gouni-Berthold I, Berthold H, Mantzoros C, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 31: 1389-1391, 2008.
31. Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation 94: 61-66, 1996.
32. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54: 2366-2373, 2009.